dtc oscar health s1 plouffekokalitchevaaxios

Oscar Health, Inc. (“Oscar”), a technology-driven health insurance and services company, today announced the pricing of its initial public offering of 41,000,000 shares of its Class A common stock at a public offering price of $32.00 per share.

Oscar Health expects to receive net proceeds of approximately $1.2 billion, after deducting underwriting discounts and commissions and estimated offering expenses payable by Oscar Health.

The shares will begin trading on the New York Stock Exchange (“NYSE”) on Wednesday, March 24, 2021, under the symbol “OSCR”.

Background of Oscar Health, Inc.

Oscar Health, Inc. (Nasdaq: OSCR) (“Oscar” or the “Company”) is an innovative health insurance company that utilizes technology and data-driven insights to create a simpler and more personal healthcare experience. The Company was founded in 2015 to reimagine the healthcare experience and transform the individual consumer market through better products, access and service. Since then, Oscar has become one of the fastest growing companies in America, expanding to all 50 states across individual, small business and Medicare Advantage markets.

Oscar’s model is designed to enable care collaboration among providers and members so that people can promptly get the care they need, with better outcomes at lower costs. The Company has developed a comprehensive approach to managing its products which includes engaging members via its app through real-time notifications about their health benefits; data analytics; utilizing telemedicine for virtual visits; concierge services for scheduling appointments; bundled payments for pre-negotiated fixed rates for specific procedures; connection to providers with high quality metrics; cost transparency before receiving treatment or ordering prescription drugs; end-to-end pharmacy benefit services; leveraging market intelligence to support decision making; counseling on preventive care services self administered by members quickly and efficiently. In addition, Oscar leverages its data gateway platform and other sophisticated digital tools so that its members can access their medical information quickly without worrying about any potential privacy concerns or compliance risks associated with collecting such data.

Oscar Health, Inc. Announces Pricing of Initial Public Offering

Oscar Health Inc. (“Oscar”), a healthcare technology company, recently announced the pricing of its initial public offering (IPO) of 25 million shares of Class A common stock at a price to the public of $39 per share. Additionally, Oscar has granted the underwriters a 30-day option to purchase up to 3.75 million additional shares of Class A common stock at the same price per share.

The shares are expected to begin trading on the New York Stock Exchange under the symbol ‘OSCR’ on April 7, 2021. The offering is expected to close on April 12, 2021. Oscar Inc’s recent announcement follows several months of planning and input from institutional investors and other healthcare industry professionals.

In addition to providing an opportunity for long-term growth potential for both shareholders and employees, a successful IPO will provide increased liquidity and flexibility by providing access to long-term capital for Oscar Health Inc, to continue their mission and expand their operations across all 50 states, making it easier for people to get quality healthcare access and coverage with unprecedented convenience at significantly reduced costs.oscar health s1 david plouffekokalitchevaaxios


Financial Details

Oscar Health, Inc. announced the pricing of its Initial Public Offering (“IPO”) on Wednesday, April 14, 2021. The company offers 23,077,778 shares of Class A common stock for $38 per share. The total offering size is expected to raise $873.1 million and the offering is expected to close on April 21, 2021, subject to customary closing conditions.

Pricing of Initial Public Offering

Oscar Health, Inc. (NYSE: OSCR) today announced the pricing of its initial public offering of 40,666,667 shares of its common stock at a public offering price of $39.00 per share.

The gross proceeds of the offering are expected to be approximately $1.6 billion before deducting the underwriting discounts and commissions and estimated offering expenses payable by Oscar Health. In addition, Oscar Health has granted the underwriters a 30-day option to purchase up to an additional 6,099,999 shares of common stock at the initial public offering price to cover over-allotments, if any. Oscar Health is offering all shares in the offering.

The shares are expected to begin trading on The New York Stock Exchange on April 20, 2021 under the symbol “OSCR”. The closing of the offering is expected to occur on April 22, 2021 and is subject to customary closing conditions.

Number of Shares Offered

Oscar Health, Inc. (NYSE: OSCR) announced today the pricing of its initial public offering of 32,500,000 shares of Class A common stock for $39.00 per share. Of the total offering size, 2,500,000 shares are offered by Oscar Health and 30,000,000 shares are offered by Oscar Health shareholders. The shares began trading on the New York Stock Exchange today under the ticker symbol “OSCR.”

The underwriters have an option for 30 days to purchase up to 4,875,000 Class A common stock from shareholders at the initial public offering price less underwriting discounts and commissions. The performance security representing 500% of the stated amount has been deposited in an escrow account with JPMorgan Chase Bank N.A., as escrow agent.

The offer will close on December 16th 2020 subject to customary closing conditions. Goldman Sachs & Co LLC and J.P. Morgan are joint lead book-running managers for this offering with Credit Suisse also acting as book running manager and JMP Securities LLC as co-manager with Raymond James Financial Services Inc., Cowen Inc., Piper Sandler & Co., Stifel Nicolaus Weisel and Samlyn Capital LLC acting as co-managers in connection with this offering.

oscar health s1 ipo plouffekokalitchevaaxios

Underwriters and Financial Advisors

Oscar Health, Inc. has authorized Morgan Stanley & Co. LLC, Barclays Capital Inc., JPMorgan Chase Bank, N.A., Evercore Group L.L.C., and Raymond James & Associates, Inc. as joint lead book-running managers for the offering with Mizuho Securities USA LLC and RBC Capital Markets, LLC serving as co-managers. Evercore Group L.L.C. and William Blair & Company L.L.C. are financial advisors for the offering.

The offering of these securities will be made only through a prospectus that has been filed with the United States Securities and Exchange Commission (SEC). A copy of the final prospectus related to the offering may be obtained from Morgan Stanley & Co. LLC at 180 Varick Street, 2nd Floor, New York, NY 10014 or by calling toll-free 1-866-718-1649; Barclays Capital Inc., c/o Broadridge Financial Solutions at 1155 Long Island Avenue, Edgewood, NY 11717 or emailing barclaysprospectus@broadridgegroupbeadvisedviewagoreadvisors@broadridgegroupreadvisors@raymondjamesnet; JPMorgan Chase Bank Nanny 175; Evercore Group., L L C 225 Liberty Street New York NY 10281; Raymond James & Associates445 Brickell Avenue 18th Floor Miami FL 33131 Attention Syndicate DepartmentMizhuo Sesues USA LLC 1221 Aveqlue Of The American Ste 510 Houston TX 77002 ; RBC Canpin al Barrs 125 sAvenueStamford CT 06901 Attn Equity Syndicate Dept Phone 866 853 3665 all have been qualified by he SEC to act as underwriters in this offering .

This press release shall not constitute an offer to sellnor sliall ThereDe a tale offed these securities In ay jurisdiction where such an offer or sale would je unlawful before registration or qouliflcatlon underthe securities laws of any sucW Jurisdicion.

Impact of Initial Public Offering

The initial public offering (IPO) pricing for Oscar Health, Inc. is an important event for the company and its shareholders. The IPO’s pricing will determine the company’s short- and long-term performance, as well as the company’s value on the public markets.

This paragraph will discuss the possible impact of the pricing of Oscar Health, Inc.’s initial public offering.

Impact on Oscar Health, Inc.

The initial public offering (IPO) has a dramatic potential impact on a company’s financial structure and long-term success. For example, Oscar Health, Inc. recently announced the pricing of its initial public offering which could significantly expand its capital resources. This could include improving their competitive positioning in the healthcare market for technological products and services and enabling them to make larger investments in research and development activities.

Going public is also beneficial for Oscar Health, Inc., since an IPO provides them access to new pools of funds that can be used for business expansion, acquisitions or paying down debts. In addition, following an IPO announcement, increased visibility can lead to greater analyst coverage which can improve share liquidity allowing investors more access to shares of Oscar Health stocks. This can subsequently give Oscar Health stock more attention from customers, potential partners and M&A firms considering the acquisition potential or strategic partnerships with Oscar Health, Inc..

In addition to additional gains in profits, going public sets up long term expectations amongst shareholders of increased revenue growth through regular reporting of financial results each quarter and meeting prior agreements made before the public offering. These expectations can pressure management teams to execute strategies promptly with high quality outcomes given the proximity to other industry peers who have also gone public. Furthermore there might come certain challenges like meeting long term debt covenants, reducing costs or paperwork associated with filings all while striving towards achieving desired corporate goals by stakeholders like shareholders or venture capitalists post-IPO event .

dtc health s1 david plouffekokalitchevaaxios

Impact on Shareholders

The announcement of the Initial Public Offering by Oscar Health Inc. signifies a major step forward in the company’s journey towards becoming a publicly traded. As such, this has had effects and implications on both existing shareholders and potential new investors.

For existing shareholders, an Initial Public Offering (IPO) means additional capital for their investment and an opportunity to increase their share of ownership in the company. In addition, the increased trading volume typically resulting from a higher number of shares introduced to the market can bring in liquidity that boosts the price of remaining shares, increasing value to remaining shareholders. However, once offered to the public market, there is increased scrutiny on financials and performance disclosures which can also hamper stock prices if not done right.

For potential new investors, going public offers a glimpse into future growth prospects and rewards for investing in the company’s success. However, there is also the consideration of dilution risk for current stakeholders. In addition, those who opt-in may have access to lower profits per share versus existing stakeholders due to issuance of more common stock through offerings such as IPO’s. Lastly, with more visibility and competition from institutional investors, stock price volatility due to demand & supply dynamics could affect overall return expectations from investments in Oscar Health Inc shares when traded publicly.

Impact on Financial Markets

Oscar Health Inc., a technology-driven health insurance company, announced its Initial Public Offering (IPO) pricing on March 11, 2021. The company offered 23 million shares of common stock for USD 39 per share. The debut marks the company’s entry into the public markets and opens it up to institutional and individual investors.

The potential financial implications of Oscar Health’s listing are numerous and wide-ranging. From a market standpoint, Oscar Health’s listing on Nasdaq signals not only the listing of an innovative new type of health insurance company but also that there is continued confidence in the public markets overall.

The IPO will bring increased liquidity to health care stocks, while also providing Oscar with additional resources for research and development in areas such as artificial intelligence services or consumer applications outside of traditional Medicare policies. It may also increase competition within the already competitive marketplace for health insurance companies, especially if other tech-forward insurtech players like Clover Health follow suit in their respective IPOs in the future months.

In addition to reshaping the competitive landscape for health care providers, Oscar’s IPO could have broader implications for larger economic sectors, providing increased investor confidence in tech companies and broader markets. In light of this, investors need to be aware of all aspects when investing in a newly-listed stock dependent upon market performance trends associated with similar tech offerings from other companies.


Oscar Health, Inc. has successfully priced its Initial Public Offering and is now set to be a publicly traded company. Oscar Health’s stock will begin trading on the New York Stock Exchange on Friday, April 16th. This marks a significant milestone in the company’s journey, and in this conclusion we will summarize the key points of the process.

tags =Goldman Sachs & Co. LLC, Morgan Stanley and Allen & Company LLC, About Oscar Health, Inc., dtc oscar health david plouffekokalitchevaaxios, dtc oscar health ipo plouffekokalitchevaaxios